Davidson Matt 13D/13G Filings for Verrica Pharmaceuticals Inc. (VRCA)

Davidson Matt 13D and 13G filings for Verrica Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-27
11:04 am
Sale
2021-12-3113GVerrica Pharmaceuticals Inc.
VRCA
Davidson Matt56,073
2.040%
-88,427decrease
(-61.20%)
Filing